{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T15:21:54Z","timestamp":1787584914046,"version":"build-2736575974"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajo.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Ophthalmology"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.ajo.2020.07.013","type":"journal-article","created":{"date-parts":[[2020,7,21]],"date-time":"2020-07-21T12:16:05Z","timestamp":1595333765000},"page":"430-445","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Analysis of Predisposing Clinical Features for Worsening Traction After Treatment of Familial Exudative Vitreoretinopathy in Children"],"prefix":"10.1016","volume":"223","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5427-438X","authenticated-orcid":false,"given":"G. Baker","family":"Hubbard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexa L.","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajo.2020.07.013_bib1","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/0002-9394(69)91237-9","article-title":"Familial exudative vitreoretinopathy","volume":"68","author":"Criswick","year":"1969","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ajo.2020.07.013_bib2","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1001\/archopht.1971.01000010152007","article-title":"Familial exudative vitreoretinopathy. An expanded view","volume":"86","author":"Gow","year":"1971","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ajo.2020.07.013_bib3","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/S0002-9394(14)75020-2","article-title":"Peripheral proliferative retinopathy without oxygen therapy in a full-term infant","volume":"90","author":"Schulman","year":"1980","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ajo.2020.07.013_bib4","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1001\/archopht.1976.03910040034006","article-title":"Fluorescein angiographic findings in familial exudative vitreoretinopathy","volume":"94","author":"Canny","year":"1976","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ajo.2020.07.013_bib5","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1136\/bjo.64.2.112","article-title":"Autosomal dominant exudative vitreoretinopathy","volume":"64","author":"Ober","year":"1980","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ajo.2020.07.013_bib6","first-page":"211","article-title":"Familial exudative vitreoretinopathy","volume":"79","author":"Tasman","year":"1981","journal-title":"Trans Am Ophthalmol Soc"},{"key":"10.1016\/j.ajo.2020.07.013_bib7","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1159\/000309234","article-title":"Retinal involvement in familial exudative vitreoretinopathy","volume":"185","author":"Miyakubo","year":"1982","journal-title":"Ophthalmologica"},{"key":"10.1016\/j.ajo.2020.07.013_bib8","first-page":"40","article-title":"Falciform retinal fold as sign of familial exudative vitreoretinopathy","volume":"27","author":"Nishimura","year":"1983","journal-title":"Jpn J Ophthalmol"},{"key":"10.1016\/j.ajo.2020.07.013_bib9","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1016\/S0161-6420(84)34119-7","article-title":"Retinal vascular pattern in familial exudative vitreoretinopathy","volume":"91","author":"Miyakubo","year":"1984","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2020.07.013_bib10","first-page":"473","article-title":"Familial exudative vitreoretinopathy","volume":"93","author":"Benson","year":"1995","journal-title":"Trans Am Ophthalmol Soc"},{"key":"10.1016\/j.ajo.2020.07.013_bib11","first-page":"323","article-title":"Familial exudative vitreoretinopathy (FEVR). Clinical profile and management","volume":"51","author":"Shukla","year":"2003","journal-title":"Indian J Ophthalmol"},{"key":"10.1016\/j.ajo.2020.07.013_bib12","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1016\/j.ophtha.2011.06.020","article-title":"Clinical presentation of familial exudative vitreoretinopathy","volume":"118","author":"Ranchod","year":"2011","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2020.07.013_bib13","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1097\/IAE.0b013e3182019c04","article-title":"Preretinal and intraretinal exudates in familial exudative vitreoretinopathy","volume":"31","author":"Day","year":"2011","journal-title":"Retina"},{"key":"10.1016\/j.ajo.2020.07.013_bib14","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1007\/s10792-012-9707-1","article-title":"Vitreomacular interface in patients with familial exudative vitreoretinopathy","volume":"33","author":"Shimouchi","year":"2013","journal-title":"Int Ophthalmol"},{"key":"10.1016\/j.ajo.2020.07.013_bib15","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1097\/ICB.0000000000000375","article-title":"Distinctive white fundus lesions in familial exudative vitreoretinopathy: a newly characterized clinical feature","volume":"11","author":"Johnson","year":"2017","journal-title":"Retin Cases Brief Rep"},{"key":"10.1016\/j.ajo.2020.07.013_bib16","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1016\/S0161-6420(98)96002-X","article-title":"Familial exudative vitreoretinopathy. Results of surgical management","volume":"105","author":"Pendergast","year":"1998","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2020.07.013_bib17","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.1016\/j.ophtha.2014.05.029","article-title":"Diversity of retinal vascular anomalies in patients with familial exudative vitreoretinopathy","volume":"121","author":"Kashani","year":"2014","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2020.07.013_bib18","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1001\/archopht.1983.01040020534004","article-title":"Autosomal dominant exudative vitreoretinopathy","volume":"101","author":"Feldman","year":"1983","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ajo.2020.07.013_bib19","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0002-9394(14)73977-7","article-title":"X-linked recessive familial exudative vitreoretinopathy","volume":"114","author":"Plager","year":"1992","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ajo.2020.07.013_bib20","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1034\/j.1399-0004.1998.5440409.x","article-title":"Autosomal recessive familial exudative vitreoretinopathy: evidence for genetic heterogeneity","volume":"54","author":"de Crecchio","year":"1998","journal-title":"Clin Genet"},{"key":"10.1016\/j.ajo.2020.07.013_bib21","first-page":"176","article-title":"Familial exudative vitreoretinopathy: pathophysiology, diagnosis, and management","volume":"7","author":"Tauqeer","year":"2018","journal-title":"Asia Pac J Ophthalmol"},{"issue":"3 Suppl","key":"10.1016\/j.ajo.2020.07.013_bib22","doi-asserted-by":"crossref","first-page":"S8","DOI":"10.1097\/IAE.0b013e3181679bf6","article-title":"Treatment of vascularly active familial exudative vitreoretinopathy with pegaptanib sodium (Macugen)","volume":"28","author":"Quiram","year":"2008","journal-title":"Retina"},{"key":"10.1016\/j.ajo.2020.07.013_bib23","doi-asserted-by":"crossref","first-page":"582","DOI":"10.3928\/15428877-20100830-03","article-title":"Bevacizumab for the treatment of pediatric retinal and choroidal diseases","volume":"41","author":"Sisk","year":"2010","journal-title":"Ophthalmic Surg Lasers Imaging"},{"key":"10.1016\/j.ajo.2020.07.013_bib24","first-page":"976","article-title":"The role of intravitreal ranubizumab in the treatment of familial exudative vitreoretinopathy of stage 2 or greater","volume":"11","author":"Lu","year":"2018","journal-title":"Int J Ophthalmol"},{"key":"10.1016\/j.ajo.2020.07.013_bib25","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/S0002-9394(14)72661-3","article-title":"Improved surgical treatment of familial exudative vitreoretinopathy in children","volume":"120","author":"Glazer","year":"1995","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ajo.2020.07.013_bib26","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1007\/BF00947005","article-title":"Familial exudative vitreoretinopathy: surgical intervention and visual acuity outcomes","volume":"235","author":"Shubert","year":"1997","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.ajo.2020.07.013_bib27","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/S0161-6420(99)90268-3","article-title":"Vitrectomy for rhegmatogenous or tractional retinal detachment with familial exudative vitreoretinopathy","volume":"106","author":"Ikeda","year":"1999","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2020.07.013_bib28","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1097\/IAE.0b013e31821c3ec5","article-title":"Clinical characteristics and surgical management of familial exudative vitreoretinopathy\u2013associated rhegmatogenous retinal detachment","volume":"32","author":"Chen","year":"2012","journal-title":"Retina"},{"key":"10.1016\/j.ajo.2020.07.013_bib29","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/j.ajo.2014.08.009","article-title":"Surgical outcomes of progressive tractional retinal detachment associated with familial exudative vitreoretinopathy","volume":"158","author":"Yamane","year":"2014","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ajo.2020.07.013_bib30","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1097\/IAE.0000000000000961","article-title":"Surgical management of advanced familial exudative vitreoretinopathy with complications","volume":"36","author":"Fei","year":"2016","journal-title":"Retina"},{"key":"10.1016\/j.ajo.2020.07.013_bib31","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1136\/bjophthalmol-2016-309526","article-title":"Anatomical and functional outcomes following vitrectomy for advanced familial exudative vitreoretinopathy: a single surgeon's experience","volume":"101","author":"Hocaoglu","year":"2017","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ajo.2020.07.013_bib32","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1007\/s00417-018-4035-4","article-title":"25-gauge lens-sparing vitrectomy with dissection of retrolental adhesions on the peripheral retina for familial exudative vitreoretinopathy in infants","volume":"256","author":"Ma","year":"2018","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.ajo.2020.07.013_bib33","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1097\/IAE.0000000000001725","article-title":"Retinal detachment surgery in a pediatric population: visual and anatomic outcomes","volume":"38","author":"Read","year":"2018","journal-title":"Retina"},{"key":"10.1016\/j.ajo.2020.07.013_bib34","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1016\/j.ophtha.2018.11.001","article-title":"Rhegmatogenous retinal detachment in children: clinical factors predictive of successful surgical repair","volume":"126","author":"Smith","year":"2019","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2020.07.013_bib35","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s10384-017-0547-4","article-title":"Surgical treatments for fibrous tissue extending to the posterior retina in eyes with familial exudative vitreoretinopathy","volume":"62","author":"Takahashi","year":"2018","journal-title":"Jpn J Ophthalmol"},{"key":"10.1016\/j.ajo.2020.07.013_bib36","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.jaapos.2015.09.006","article-title":"Long-term follow-up of intravitreal bevacizumab for the treatment of pediatric retinal and choroidal diseases","volume":"19","author":"Henry","year":"2015","journal-title":"J AAPOS"},{"key":"10.1016\/j.ajo.2020.07.013_bib37","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.ajo.2011.06.002","article-title":"Clinical features of congenital retinal folds","volume":"153","author":"Nishina","year":"2012","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ajo.2020.07.013_bib38","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1001\/archopht.122.11.1717","article-title":"Progression of familial exudative vitreoretinopathy after laser treatment","volume":"122","author":"Margolis","year":"2004","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ajo.2020.07.013_bib39","first-page":"45","article-title":"Familial exudative vitreo-retinopathy","volume":"99","author":"Dudgeon","year":"1979","journal-title":"Trans Ophthalmol Soc UK"},{"key":"10.1016\/j.ajo.2020.07.013_bib40","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/S0161-6420(81)34978-1","article-title":"Photocoagulation treatment of proliferative diabetic retinopathy: clinical application of diabetic retinopathy study (DRS) findings, DRS report number 8","volume":"88","year":"1981","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2020.07.013_bib41","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1001\/archopht.121.12.1684","article-title":"Revised indications for the treatment of retinopathy of prematurity: results of the early treatment for retinopathy of prematurity randomized trial","volume":"121","year":"2003","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ajo.2020.07.013_bib42","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1001\/archopht.1990.01070040047029","article-title":"Multicenter trial of cryotherapy for retinopathy of prematurity: three-month outcome","volume":"108","year":"1990","journal-title":"Arch Ophthalmol"},{"issue":"10208","key":"10.1016\/j.ajo.2020.07.013_bib43","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1016\/S0140-6736(19)31344-3","article-title":"Ranibizumab versus laser therapy for the treatment of very low birthweight infants with retinopathy of prematurity (RAINBOW): an open-label randomised controlled trial","volume":"394","author":"Stahl","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.ajo.2020.07.013_bib44","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1001\/jama.2015.15217","article-title":"Panretinal photocoagulation vs intravitreous ranibizumab for proliferative diabetic retinopathy: a randomized clinical trial","volume":"314","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/j.ajo.2020.07.013_bib45","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1136\/bjo.2007.127142","article-title":"Tractional retinal detachment following intravitreal bevacizumab (Avastin) in patients with severe proliferative diabetic retinopathy","volume":"92","author":"Arevalo","year":"2008","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ajo.2020.07.013_bib46","doi-asserted-by":"crossref","first-page":"e2675","DOI":"10.1371\/journal.pone.0002675","article-title":"The angio-fibrotic switch of VEGF and CTGF in proliferative diabetic retinopathy","volume":"3","author":"Kuiper","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.ajo.2020.07.013_bib47","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1136\/bjophthalmol-2011-301005","article-title":"A shift in the balance of vascular endothelial growth factor and connective tissue growth factor by bevacizumab causes the angiofibrotic switch in proliferative diabetic retinopathy","volume":"96","author":"Van Geest","year":"2012","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ajo.2020.07.013_bib48","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.ophtha.2010.08.038","article-title":"Preoperative intravitreal bevacizumab use as an adjuvant to diabetic vitrectomy: histopathologic findings and clinical implications","volume":"118","author":"El-Sabagh","year":"2011","journal-title":"Ophthalmology"}],"container-title":["American Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939420303640?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939420303640?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T13:47:08Z","timestamp":1757598428000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002939420303640"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":48,"alternative-id":["S0002939420303640"],"URL":"https:\/\/doi.org\/10.1016\/j.ajo.2020.07.013","relation":{},"ISSN":["0002-9394"],"issn-type":[{"value":"0002-9394","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Analysis of Predisposing Clinical Features for Worsening Traction After Treatment of Familial Exudative Vitreoretinopathy in Children","name":"articletitle","label":"Article Title"},{"value":"American Journal of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajo.2020.07.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}